The trademark was filed by Guardant Health, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 3, 2021, and received one opposition filed on September 5, 2021 by RENOVA-FĂBRICA DE PAPEL DO ALMONDA, S.A. on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by J. PEREIRA DA CRUZ, S.A. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 5, 2021
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Scientific research for medical purposes in the area of cancerous diseases
Structural and functional analysis of genomes
Providing a website in connection with information in the field of cancerous diseases for scientific purposes.
The mark was filed in class 44 with following description of goods:
Medical services for the treatment of cancer
Medical analysis services for the diagnosis of cancer
Medical analysis services for cancer diagnosis and prognosis
Providing cancer screening services
RNA or DNA analysis for cancer diagnosis and prognosis
Healthcare services, namely, providing a database in the field of cancer related information and featuring inputting and collection of data and information for treatment and diagnostic purposes
Medical testing for diagnostic or treatment purposes
Providing cancer recurrence and monitoring services in the nature of providing medical diagnostic testing services consisting primarily of chemical analysis and use of bioinformatics tools for cancer detection
Providing a website in connection with information in the field of cancerous diseases for diagnostic and treatment purposes
Providing a website in connection with information in the field of cancerous diseases for medical purposes.